Clinical Trials Directory

Trials / Conditions / Metastatic

Metastatic

22 registered clinical trials studyying Metastatic — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingBiomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors
NCT07523529
Beijing BiotechPhase 1 / Phase 2
Not Yet RecruitingA Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer
NCT07363330
Zhongnan HospitalPhase 2
CompletedPhase I Trial of Combined Immune Cell Therapy for Metastatic Stage IV Solid Tumors (SDH-Combi)
NCT06296056
Seoul HospitalPhase 1
RecruitingA Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer
NCT06007937
Memorial Sloan Kettering Cancer CenterPhase 1 / Phase 2
RecruitingPRE-I-SPY Phase I/Ib Oncology Platform Program
NCT05868226
QuantumLeap Healthcare CollaborativePhase 1
RecruitingSurufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine o
NCT05472948
Sun Yat-sen UniversityPhase 2
CompletedStudy of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer
NCT05673811
Theriva Biologics SLPhase 2
WithdrawnLeronlimab in Combination With Regorafenib in Patients With CCR5+, Metastatic Colorectal Cancer
NCT05730673
CytoDyn, Inc.Phase 2
Active Not RecruitingTargeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma
NCT05496686
Modulation Therapeutics, Inc.Phase 1
WithdrawnISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With
NCT04602117
QuantumLeap Healthcare CollaborativePhase 1
RecruitingA Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Sing
NCT04333706
University of Southern CaliforniaPhase 1 / Phase 2
CompletedTrial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metasta
NCT02639026
Abramson Cancer Center at Penn MedicinePhase 1
CompletedA Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes
NCT02069730
University Health Network, TorontoN/A
CompletedSelumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Metastatic Uveal Melanoma (SUMIT)
NCT01974752
AstraZenecaPhase 3
CompletedStudy of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue Sarcoma
NCT01719744
University Health Network, TorontoPhase 2
CompletedFeasibility Study of Genomic Profiling Methods and Timing in Tumor Samples
NCT01703585
University Health Network, Toronto—
CompletedCohort Study of Prospective Validation of Predictive Factors and Biological Imaging of Response to Bevacizumab
NCT01745757
UNICANCER—
CompletedBortezomib in Combination With Gemcitabine and Cisplatin in Advanced or Metastatic Non-Small Cell Lung Cancer
NCT01633645
University Hospital of CretePhase 2
UnknownSecond-Line Irinotecan vs. ILF for AGC
NCT00509964
Gachon University Gil Medical CenterPhase 2
CompletedCetuximab + Gemox in Biliary Tract Cancer
NCT01216345
Association of Research on the Biology of Liver TumorsPhase 2
CompletedE3-Hormone Refractory Prostrate Cancer Taxotere Combination
NCT00498797
SanofiPhase 2
CompletedPhase I Irinotecan, 5-Fluorouracil and Leucovorin Combination
NCT00507091
Genzyme, a Sanofi CompanyPhase 1